Bagging/Receiving of orders/contracts Bajel Projects Limited has informed the Exchange about Bagging of order of EHV Substation. Bajel Projects Limited has informed the Exchange about Bagging of order of EHV Substation.
Bagging/Receiving of orders/contracts Bajel Projects Limited has informed the Exchange about Bagging of order of EHV Substation. Bajel Projects Limited has informed the Exchange about Bagging of order of EHV Substation.
Company Update Announcement under Regulation 30 (LODR) - Bagging of order of EHV Substation Announcement under Regulation 30 (LODR) - Bagging of order of EHV Substation
Company Update Announcement under Regulation 30 (LODR) - Bagging of order of EHV Substation Announcement under Regulation 30 (LODR) - Bagging of order of EHV Substation
ITAT New Delhi dismissed the Income Tax Officer's appeal against Fusion Finance, providing clarity on the company's tax position under the Income Tax Act, 1961.
Kalpataru Limited has withdrawn its scheme of arrangement for demerging Kalpataru Properties Limited into the parent company, signaling a shift in corporate structure plans.
Company Update Transcript of Earnings Call held on 29th May, 2026. Transcript of Earnings Call held on 29th May, 2026. Transcript of Earnings Call held on 29th May, 2026. Transcript of Earnings Call held on 29th May, 2026.
Company Update Transcript of Earnings Call held on 29th May, 2026. Transcript of Earnings Call held on 29th May, 2026. Transcript of Earnings Call held on 29th May, 2026. Transcript of Earnings Call held on 29th May, 2026.
Company Update Shilpa Biocare Private Limited, a wholly owned Subsidiary of Shilpa Medicare Limited, intends to make a strategic equity partnership in Gate2Brain. Shilpa Biocare Private Limited, a wholly owned Subsidiary of Shilpa Medicare Limited, intends to make a strategic equity partnership in Gate2Brain.
Company Update Shilpa Biocare Private Limited, a wholly owned Subsidiary of Shilpa Medicare Limited, intends to make a strategic equity partnership in Gate2Brain. Shilpa Biocare Private Limited, a wholly owned Subsidiary of Shilpa Medicare Limited, intends to make a strategic equity partnership in Gate2Brain.
Press Release Shilpa Medicare Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Shilpa Biocare Pvt Ltd, a Wholly owned Subsidiary of Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy". Shilpa Medicare Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Shilpa Biocare Pvt Ltd, a Wholly owned Subsidiary of Shilpa Medicare and Gate2Brain Sign Strategic Equity Par
Press Release Shilpa Medicare Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Shilpa Biocare Pvt Ltd, a Wholly owned Subsidiary of Shilpa Medicare and Gate2Brain Sign Strategic Equity Partnership to Advance First-in-Class Brain Cancer Therapy". Shilpa Medicare Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "Shilpa Biocare Pvt Ltd, a Wholly owned Subsidiary of Shilpa Medicare and Gate2Brain Sign Strategic Equity Par
NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.